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Parasitic helminths must establish chronic infections to complete their life cycle and therefore are potent modulators of multiple facets of host physiology. Parasitic helminths have coevolved with humans to become arguably master selectors of our immune system, whereby they have impacted on the selection of genes with beneficial mutations for both host and parasite. While helminth infections of humans are a significant health burden, studies have shown that helminths or helminth products can alter susceptibility to unrelated infectious or inflammatory diseases. This has generated interest in the use of helminth infections or molecules as therapeutics. In this review, we focus on the impact of helminth infections on pulmonary immunity, especially with regard to homeostatic lung function, pulmonary viral and bacterial (co)infections, and asthma.
Helminth Infections Influence the Lung Environment
The fascinating life cycles of helminths can include multiple intermediary hosts, different routes of entry into the human body, and migration within the host from the point of entry to the location where sexual propagation of the worm's life cycle takes place. These migratory routes depend on the helminth species and may lead them through the lung, either as a developmental step or simply to transit from within the body (tissue, blood vessels) to the luminal space of the lung or intestine. The life cycles of a range of helminth species involve the migration of developing larvae through the lung of the infected host, as well as entry of adult worms or the deposition of eggs into the lungs, all of which cause pulmonary tissue damage and pathology (Table 1) . A paradox is why certain helminths that reside in the intestine or other tissue sites as adults have evolved to need a lung migration phase as part of their life cycle [1] .
Here, we summarise recent data on the interplay of helminths and the pulmonary immune response, review recent literature on novel helminth-derived immunomodulators that might be useful as therapeutics, and highlight the impact helminths have on bacterial and viral coinfections.
Helminth Infections Induce Damage to the Lung
The migration of the larvae of helminths such as Schistosoma mansoni, Ascaris lumbricoides, and hookworms (Necator americanus or Ancylostoma duodenale) through the lung has been particularly well investigated. Pulmonary damage caused by helminths leads to the development of a type 2 immune response (Figure 1 ), which is associated with wound healing, with active immunomodulation by the parasite leading to long-term changes in lung function.
There are several ways through which helminths influence pulmonary immunity -either by direct damage caused by migration, the dissemination of eggs, or the release of immunomodulators -all of which alter normal pulmonary function and modify responses against further insults.
Migrating Larvae Inflict Damage and Induce Wound Healing in the Lung
While the migrating larvae of hookworms cause mechanical and enzymatic damage to the lung parenchyma and epithelium, with patients presenting with coughing, wheezing, and Helminths influence the lung immune response by direct damage, active immunomodulation, and initiation of regulatory mechanisms. Differences exist when worms modulate pulmonary responses systemically or alter responses as a consequence of damage responses.
Migration of larvae through the lung triggers a wound-healing response.
Helminths introduce immunoregulation into Th2 responses, a quality which is not present in allergic responses.
Helminths and their immunomodulatory molecules ameliorate lung inflammation, including asthma.
Helminth coinfections impair responses against viral and (myco-) bacterial pulmonary infection.
eosinophilic pneumonia (Löffler's syndrome, see Glossary), there is remarkable repair of pulmonary pathology postmigration. Experimental studies with the rodent hookworm Nippostrongylus brasiliensis have led to many discoveries, not only on helminth-induced lung damage and repair, but also aiding fundamental insights into immune function. The importance of the modulation of pulmonary immunity during hookworm infection is evident from recent studies demonstrating a link between innate immune cellular responses and signals derived from the central nervous system (CNS). This is demonstrable by the discovery of group 2 innate lymphoid cells (ILC2) in N. brasiliensis-infected mice [2] [3] [4] . ILC2s express the receptor for the neuropeptide neuromedin U (NMUR), with NMU signaling (through the NMUR) integrating CNS-derived signals with immunity to mount a robust innate antiparasite type 2 pulmonary response in the lungs of hookworm-infected mice [5] [6] [7] . Indeed, another critical cell type in the immune response against hookworms is the Tuft cell, which contributes to expel the worms from the intestine using a feed-forward loop: Tuft cells can sense the presence of helminths via chemosensory receptors, leading to the release of interleukin (IL)-25, which activates intestinal ILC2s. ILC2s then release IL-13, thereby promoting both Tuft cell and goblet cell hyperplasia [8] [9] [10] . In the lungs, a phenotypically similar cell type to the intestinal Tuft cell -the brush cell -is present and may exert similar functions in the genesis of pulmonary type 2 immunity [11] , although this has not been formally addressed to our knowledge.
A hallmark of worm-induced lung damage is long-term alteration in the structure of the lung. IL-13 release during infection leads to type 2 macrophage (M2) polarization of resident and recruited mononuclear cells, which persists for months after the adult worms are expelled from the intestines [12] . During experimental hookworm infection, neutrophils and monocytes are quickly recruited to the damaged lung. The release of the chitinase-like protein Ym1 from M2-polarised macrophages promotes the mobilisation and recruitment of neutrophils to the lung, and an early increase in IL-17A from gd T cells further contributes to helminth-induced pulmonary damage [13] . Additionally, progressive lung destruction can be observed long after infection, as evidenced by long-lasting emphysema-like lesions in the lungs of previously infected mice [12] . Interestingly, although hookworm-infected mice show an increase in transcripts of both CD4 T helper (Th)1-and Th2-associated cytokines in the lung, allergen sensitization and challenge results in a decrease in allergen-specific Th2 responses and reduced inflammation [14] . It has further been reported that Th1 and Th17 cells can be converted to IL-4-expressing Th2 cells [15] and, using fate reporter mice, it has been shown that Th17 cells induced during primary infections with N. brasiliensis can be converted into regulatory Tr1 cells to prevent overt pulmonary inflammation during a subsequent encounter [16] . In summary, the intricate network of cellular interactions in response to larvae-inflicted damage changes the pulmonary cellular composition and acts to limit damage while allowing for efficient protective immunity [17] .
Dissemination of Eggs and Hyperinfection Severely Impair Lung Function
In addition to damage caused by larval migration, damage to the lung can be caused by the unchecked dissemination of worms from other sites, as well as the deposition of eggs into the lung. Life-threatening pulmonary damage can be caused by hyperinfection with Strongyloides due to an autoinfectious cycle, which is mostly seen in immunocompromised individuals. Here, infective larvae penetrate the intestinal wall and enter the lung via the bloodstream, leading to oedema, dyspnoea, and pleural effusion (reviewed in [1] ).
Although schistosomulae migrate through the lung, the main pulmonary pathology of Schistosoma infection manifests after eggs are deposited in the bloodstream and disseminated by the adult worms residing in the mesenteric venules. Because of their size and shape, the highly immunogenic eggs are lodged in the pulmonary blood vessels, transmigrate into the lung parenchyma, and are encapsulated by a type 2 granuloma. The initial granuloma consists of mainly T cells and eosinophils [18] . The composition of the granuloma changes over time with the accumulation of collagen-depositing M2 macrophages becoming more and more fibrotic, leading to pulmonary hypertension [18] .
The necessity of a functional Th2 response becomes evident in Schistosoma infections where the initial Th1 response switches towards a Th2 response after deposition of Schistosoma eggs [19] . Mice incapable of mounting a Th2 response are unable to facilitate egg transition and initiate wound repair processes, and so succumb to the infection [20, 21] . Similarly, mice with impaired Th2 induction (IL-4Ra
) are unable to expel N. brasiliensis due to the lack of a functional Th2 response [22, 23] . However, during chronic stages of Schistosoma infection, regulatory T and B cells limit the Th2 response to prevent immunopathology [24, 25] .
Release of Helminth-Derived Immunomodulators Regulates Pulmonary Inflammation Although Brugia malayi microfilariae only circulate in the blood of their human hosts, they can alter immune responses in the lungs. Adaptation of B. malayi to its host and vector (mosquito) has led to a synchronised circadian rhythm, whereby the microfilariae are present in the blood when the mosquito feeds; at other times they are sequestered to the lung capillaries [26] . Continuous presence of the microfilariae within the pulmonary circulation requires the downregulation of the immune response by helminth-secreted immunomodulatory molecules, mainly targeting eosinophils, which are required for protection from B. malayi. Limiting eosinophil responses within the lung has a concomitant beneficial effect on allergic airway responses, during which eosinophils are the main effector cells eliciting inflammation [27] .
Most interesting are helminth species that are able to modulate pulmonary responses while never physically entering or residing in the lung. The gastrointestinal nematode Heligmosomoides polygyrus attenuates airway inflammation by directly releasing mediators in their excretory-secretory (ES) products, such as a transforming growth factor (TGF)-b mimic, which induces regulatory T cells (Tregs) in vitro and in vivo [28] . Another intriguing mechanism by which Tregs can be induced during helminth infection was revealed in a recent study showing that H. polygyrus modulates the caecal microbiome. Changes in the microbiome composition introduced by H. polygyrus infection increased the availability of microbial-derived short-chain fatty acids, which alters pulmonary Treg function via the cognate short-chain fatty acid receptor GPR41, thereby reducing lung inflammation [29] .
As there is a body of data showing that the intestinal microbiota and its interaction with the gut epithelia shapes immune responses at distal sites, such as the lung, changes introduced by infection with gastrointestinal worms may also influence immune responses in the lung. A study conducted with Schistosoma haematobium-infected children observed significant changes in the composition of the faecal microbiome compared to uninfected children [30] . Praziquantel treatment to remove the worms did not alter the microbiome composition [30], arguing for longlasting changes of the intestinal microbiome imposed by the parasite. During schistosomiasis, egg translocation from the blood vessels through the intestinal epithelium into the lumen causes constant immunomodulation through disseminated bacteria. However, at the same time, regulatory macrophages -T and B cells induced during Schistosoma infection -prevent a cytokine storm and concomitantly protect against excessive lung inflammation [24,31-33]. It remains to be determined to what extent alterations of the microbiota influence the regulatory networks underlying schistosomiasis. While other helminths alter the microbiome composition or migrate from the intestine into the lung (Ascaris), it is unclear whether these changes modulate pulmonary immune responses. Infections with Schistosoma and Heligmosomoides illustrate that the presence of the helminth within the lung is not required to influence pulmonary responses and rather the release of parasite-derived immunomodulatory molecules may have systemic effects, including influencing lung inflammation.
In conclusion, helminth-induced lung inflammation is initiated in distinctive processes that prompt a wound-healing response or directly act on mechanisms of wound healing.
The Wound-Healing Response
Migration of helminth larvae damages the lung epithelia, hence it is in both the host's and the helminth's interest to repair it and restore lung function ( Figure 2 ). Typically, damage is induced in areas where larvae breach through the alveolar epithelia and destroy respiratory epithelial cells. This causes emphysema-like lesions, including formation of blood clots, and the release of damage-associated molecular patterns (DAMPs), such as chromatin-associated highmobility group box 1 (HMGB-1), extracellular DNA/RNA, or nucleotides, S100-proteins, and alarmins. Tissue-resident macrophages sense these DAMPs and induce a proinflammatory environment followed by the recruitment of circulating CCR2/CX3CR1 + monocytes (reviewed in [34] ). The recruited monocytes differentiate into macrophages and assist resident macrophages with tissue formation: macrophage-derived growth factors induce differentiation and proliferation of cells and induce extracellular matrix deposition. Importantly, successful wound healing requires prevention of the influx of more proinflammatory cells [35] . Resolution of inflammation is achieved through the phagocytosis of apoptotic neutrophils, which acts as a trigger for macrophages to release the anti-inflammatory cytokines TGF-b and IL-10, for the blockade of proinflammatory IL-1 signalling, and the release of arginase-1 (Arg-1) and amphiregulin (AREG), which reduce inflammation and promote tissue formation [34, 36] . [112] [113] [114] . Th2 cells are then instrumental in recruiting basophils to the lung and provide help to B cells to produce IgG1, IgG4, and IgE isotype-switched antibodies. While the immune response in the intestine develops and expels the parasite via a weep-and-sweep-reaction in an IL-13-dependent manner, in the lung tissue repair and remodelling are initiated. This process starts with the early release of IL-17A and the recruitment of neutrophils (Neutro) and monocytes to the site of damage. IL-4Ra-dependent alternative activation of macrophages (M2) initiates wound healing and tissue remodelling involving amphiregulin (AREG) and IL-9. During a second infection with N. brasiliensis, IgE-dependent activation of basophils (Baso) and their release of type 2 cytokines accelerates worm expulsion [103] . The Insult of Helminths and Allergens on Epithelial Cells. Both helminths and allergens evoke a strong type 2 immune response but while helminths induce immunoregulation, allergen encounters can result in uncontrolled chronic inflammation. Infection of the lung epithelium by helminths, or inhalation of allergens, trigger a cascade of cellular immune processes involving the crosstalk of dendritic cells (DCs), group 2 innate lymphoid cells (ILC2) and CD4 T cells to promote the release of type 2-associated cytokines (blue box: ILC2-derived; orange box: T cell-derived). Expansion of Th2 and Th17 cells promotes eosinophilia, basophilia, and class switching to type 2-associated antibody isotypes in B cells (IgE, IgG1, IgG4). Basophils (Baso) enhance Th2 polarisation through the release of IL-4, eosinophils release TGFb and IL-13. This cascade culminates in the activation of profibrotic macrophages, smooth muscle contraction, and mucus production. During helminth infection, regulatory cells (Treg, Breg, M2 macrophages) are induced via migration-induced damage and helminth-derived immunomodulatory molecules. Immunoregulation leads to the preferential switch to
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Helminth Migration Promotes an Anti-inflammatory Environment in the Lung
In the context of helminth infection, epithelial-derived alarmins, such as IL-25 and IL-33, are released, which mainly act on ILC2s, but also macrophages, dendritic cells (DCs), mast cells, basophils, and CD4 T cells to promote the expression of type 2 cytokines, such as IL-4 and IL-13. During the initial damage response, IL-4Ra signalling in macrophages is required to suppress haemorrhaging and neutrophil influx, the main contributors to pathology during N. brasiliensis infection [37] . IL-4-induced expression of insulin-like growth factor 1 (IGF- The epidermal growth factor receptor (EGFR) ligand AREG is associated with wound repair in the gut [45] and lung [43] and can be produced by CD4 T cells, mast cells, and ILC2 [46] . AREG is essential for the optimal function of Treg cells and damage repair during hookworm infection. Recently, it was shown that EGFR -in response to AREG-mediated activation -forms a complex with IL-1 receptor family member ST2 to allow for IL-33-mediated IL-13 expression, and mice with EGFR-deficient T cells showed impaired resistance to hookworm infections [47] . EGFR expression on Th2 cells was induced in an antigen-dependent manner, and the presence of a functional ST2-EGFR heterodimer renders Th2 cells responsive to IL-33, thereby promoting an innate-like response from previously antigen-licensed Th2 cells [45] .
For humans in helminth-endemic areas, continuous exposure and risk of repeat infections raise the possibility that the recurring transmission of larvae may lead to increased or reduced pulmonary inflammation. Experimentally, daily low-dose (trickle) infections could be used as a model to investigate the impact of such reinfections on lung inflammation.
Most helminth infections induce anti-inflammatory macrophages and regulatory T cells, and the expression of IL-10, TGF-b, IL-9, and AREG, which have important roles in the control of lung blocking IgG4 antibodies, whereas allergens promote proinflammatory isotypes, such as IgG1. In the end, helminthinduced pulmonary inflammation results in self-limiting wound repair, while unregulated tissue damage and fibrosis develops in response to allergens. [ 3 6 9 _ T D $ D I F F ] Abbreviations: IL, interleukin; TSLP, thymic stromal lymphopoietin; ILC2, group 2 innate lymphoid cells; Th, T helper; AREG, amphiregulin; Breg, regulatory B cell; Treg, regulatory T cell; Baso, basophil granulocyte; Eo, eosinophil granulocyte; TGFb, transforming growth factor bÁ repair. These regulatory pathways can either be activated intrinsically or enforced by helminth products, which -as a side effect -also limit inflammation.
Helminth Immunomodulatory Molecules Enforce Anti-inflammatory Responses
Associations between the increased prevalence of asthma in developing countries undergoing parasite-elimination programs has led to interest in using helminths to treat asthma [48] . A 2014 longitudinal study showed decreased asthma morbidity in endemic areas of Brazil [49] . However, ascariasis has been shown to be strongly associated with the development of asthma in rural China [50] and indeed, infection with Ascaris suum is used as a model of asthma in nonhuman primates [51] . Unsuccessful trials in using whipworms in the treatment of inflammatory bowel disease, inconclusive results in a meta-analysis of efficacy of helminth treatment [52] , and positive association between Ascaris and asthma [53] , as well as the paucity of in-depth knowledge on helminth immunobiology [54] , calls for caution in assessing the efficacy of iatrogenic helminth therapies [55] . Administration of Trichuris suis ova (TSO) -the pig whipworm -is the most prominent example in which live helminths have been used to treat illness, inflammatory bowel diseases in this case [56] . However, TSO failed to treat allergic rhinitis [57] ; TSO infection is self-limiting and clears within a few weeks, which raises the question as to whether TSO robustly induces a long-lasting anti-inflammatory environment or whether the lack thereof caused the trials to fail. A small cohort trial using the human hookworm N. americanus to treat asthma showed a small improvement in airway function [58] . However, more extensive studies are required À especially in the light of promising results using N. americanus to treat celiac disease during which immunoregulation was established [59] .
Numerous studies -including those using mouse models of asthma -have found a beneficial effect of helminth products on pulmonary allergic responses, either during initial [ 3 7 7 _ T D $ D I F F ] sensitisation or during the effector phase of the response. Helminths excrete and secrete a plethora of immunomodulatory molecules that act in a range of inflammatory processes and have potential as novel anti-inflammatory compounds [57] . Administration of ES-antigen preparations from several helminths during allergen sensitisation suppresses the development of allergic inflammation [60, 61] . A common theme is the modulation of the Th2 response towards a Th2 plus Treg-like response (the so-called modified Th2 response) [62] . Other helminth ES proteins are also capable of inhibiting an established Th2 response when administered during the challenge phase [61] . Nippostrongylus ES products elicit a Th2 response by modulating DC function, while suppressing proinflammatory Th1 responses through inhibition of IL-12p70 release from DCs [63] .
We will not address the spectrum of helminth immunomodulatory molecules that can modulate immunity in detail herein, as this has been reviewed previously [54, 64, 65] . We will now highlight recent advances on selected novel immunomodulatory molecules or modulatory mechanisms that have been shown to alter lung inflammation (Figure 3 ).
Filarial ES-62 and Av17
One of the most extensively investigated helminth immunomodulatory molecules is the secreted glycoprotein ES-62 from the filarial nematode Acanthocheilonema viteae. ES-62, due to phosphorylcholine moieties, has been shown to have potent modulatory effects in a range of animal models of inflammatory diseases [66] . In mouse models of allergen-induced [ 3 7 7 _ T D $ D I F F ] sensitisation of the lungs, ES-62 has been shown to prevent the development of lung inflammation with the modulation of mast cells [67] , as allergen-specific responses and alteration in the cytokines and downstream eosinophilia compromise lung functions [66, 68] . [116] , and the release of neutrophil inhibitory factor (NIF) from A. caninum [117] target eosinophil recruitment (eoatxin is cleaved) and survival (increased apoptosis). Schistosoma mansoni-derived IPSE/alpha-1 (interleukin-4-inducing principle from S. mansoni eggs) activates basophils via IgE to release IL-4 independently of antigen-specificity [118] . Neutrophil recruitment and inhibition of neutrophil proteases is targeted by N. americanus ASP-2 (Ancylostoma secreted protein-2) [119] , B. malayi SPN-2 (serine protease inhibitor-2) [120] , S. mansoni CKBP (chemokine-binding protein) [121] , N. brasiliensis ES [122] , and A. caninum NIF. Antigenpresentation and alternative activation of macrophages is impaired through A. [ 3 7 0 _ T D $ D I F F ] viteae Av17, cathelicidine-like proteins [123] , ES of N. brasiliensis and H. polygyrus, and B. malayi macrophage inhibitory factor (MIF) [124] . [127] . This (nonexhaustive) list of immunomodulators acting on numerous host cell populations illustrates how helminth parasites are able to target different mechanisms in order to create an anti-inflammatory environment in the lung. Helminth infection is beneficial for the host by inducing protective immunity, establishing regulatory cells, and protecting from exaggerated airway inflammation. At the same time, pulmonary immune responses against (myco-)bacterial and viral pathogens relying on a proinflammatory Th1 response are impaired.
ILC2
A number of small-molecule analogues of ES-62 have been designed, with two small-molecule analogues (11a and 12b) that recapitulate the therapeutic actions of the parent helminth molecules [69] by targeting DCs [70] . In addition to ES-62, A. [ 3 7 0 _ T D $ D I F F ] viteae expresses the cystatin Av17, which suppresses airway inflammation when administered at the sensitization stage or before challenge, in an IL-10-and macrophage-dependent manner [71] .
Schistosoma and B Regulatory Cells
In mice, anaphylaxis is mechanistically prevented by S. mansoni infection through the induction of IL-10-producing B regulatory (Breg) cells [31] . Importantly, an expansion of Breg cells also occurs in Schistosoma-infected humans [72] . Recently, it was shown that schistosome egg antigens, including IPSE/alpha-1, can drive the expansion of Breg cells and inhibit airway inflammation [73, 74] . Bregs induced with schistosome soluble egg antigens (SEA) were shown to mediate suppression of effector Th17 cells via Treg expansion, favouring the development of IL-4-expressing Th2 cells [75] . While Breg cells are the main immunomodulatory cells during schistosomiasis, cyclophilin A from SEA has recently been shown to drive Treg differentiation via DC modulation [76] . In conclusion, Schistosoma-derived products are inducers of a potent regulatory network that functions to suppress inflammation at distal sites, thereby protecting against airway inflammation. Similarly, Bregs induced during intestinal H. polygyrus infection suppressed lung pathology following allergen challenge independent of B cell-derived IL-10 [77] .
Nematodes and Tregs In addition to Bregs, H. polygyrus potently induces Tregs with a TGF-b-like protein found to be responsible for expansion of Tregs [78] . Transfer of Tregs expanded in the presence of H. polygyrus-ES (HES) protected against allergen-induced pathology, whereas mammalian TGFb-derived Tregs were less effective [78] . Schistosoma-derived Omega-1 was also shown to induce Tregs in a TGF-b-and retinoic acid-dependent manner [79] . Recently, anti-inflammatory protein-2 (AIP-2) was identified, which is a hookworm-secreted protein that suppresses airway inflammation in mice, reduces costimulatory markers on human DC, and suppresses T cell proliferation from allergic subjects. Suppression in mice was dependent on CD103 + H. polygyrus-mediated IL-33 Inhibition A novel mechanism of inhibiting pulmonary innate immune responses has recently been published [81] . The H. polygyrus-derived Alarmin Release Inhibitor (HpARI) binds IL-33 and thereby prevents the activation of ILC2s. Recombinant HpARI administered to N. brasiliensisinfected mice inhibited eosinophilia in the lungs and prevented eosinophilic inflammation in a model of asthma using Alternaria allergen administration [73] .
Recent progress made in identifying single helminth-derived immunomodulatory molecules highlights their potency to enforce an anti-inflammatory environment without the need for a naturally occurring anti-inflammatory wound-healing response. It is tempting to speculate that these evolved to ensure the parasites' survival in a host already primed for an antiviral or antibacterial Th1-biased response within the lung.
The Helminth-Induced Anti-inflammatory Environment Influences Pulmonary Bacterial and Viral Coinfections
Coinfections of helminths and Mycobacterium tuberculosis are certainly among the most clinically relevant coinfections worldwide. Protective immunity against M. tuberculosis infection is dependent on a strong Th1 response, and most M. tuberculosis-infected people remain latently infected and asymptomatic; however, they run a 10% lifetime risk of reactivation of the disease [82] . The direct influence of helminth infection on activation of tuberculosis is not completely understood. Studies on M. tuberculosis and helminth coinfections showed decreased protection against M. tuberculosis conferred by bacille Calmette-Guérin (BCG) vaccination in individuals coinfected with helminths [83] , and experimentally coinfected animals have an impaired BCG-specific Th1 response [84] . Recently, it was shown that M. tuberculosisinfected mice coinfected with S. mansoni or injected with SEA, in addition to impaired Th1 responses, accumulated Arg-1-expressing macrophages in the lung, leading to exacerbated disease severity and inflammation -all of which were reversed by anthelmintic treatment [85] . However, no association between gastrointestinal parasite or filarial nematode infection and progression to active tuberculosis was found in HIV-positive populations in Brazil and Uganda [86, 87] . Further, a longitudinal study conducted in Southern India found no significant difference in progression from latent to active tuberculosis (or severity thereof) between individuals who were infected with helminths at the beginning of the study and uninfected individuals [88] .
Mice infected with the helminth Taenia crassiceps or H. polygyrus developed more severe pneumonia upon infection with Streptococcus pneumoniae, but not with influenza or Staphylococcus aureus infection [89] , although further studies are required to explain the observation. When mice are coinfected with H. polygyrus and Bordetella bronchiseptica, both infections are altered: bacterial burdens are higher, leading to increased host mortality, and animals exhibit higher worm burdens and therefore shed more parasite eggs [90] .
Studies investigating helminth coinfections during viral infections have found that helminths and their products create an environment favouring the helminth while shutting down antiviral immunity, which is particularly important in the context of HIV infection and treatment, as anthelmintic regimens increase the responsiveness to antiretroviral therapy [91] . With regard to pulmonary inflammation, it was shown that mice already infected with Trichinella spiralis [92] did not contain subclinical norovirus infection, a result that was independent of the intestinal microbiome and in part rescued by inactivation of the chitinase-like protein Ym1 of macrophages. In another study, mice were infected with dormant g-herpesvirus or Kaposi's sarcomaassociated herpesvirus, which were reactivated when the mice were infected with H. polygyrus or S. mansoni [93] . Conversely, a recent study revealed that mice infected with H. polygyrus were partly protected from respiratory syncytial virus (RSV) infection, measured by reduced viral load and lung inflammation, a mechanism independent of the adaptive immune system and IL-4R[ 3 7 9 _ T D $ D I F F ] a [94] . H. polygyrus itself induced the pulmonary expression of interferon b, and interferonstimulated genes, and augmented its expression in response to RSV infection. Interestingly, H. polygyrus-induced protection from RSV was dependent on the presence of microbiota, as it was absent in germ-free or antibiotic-treated mice, but further mechanistic studies are required to understand the link in this particular model [94] . Recently, AvCystatin/Av17, a recombinant cysteine protease inhibitor derived from the filarial nematode A. viteae, was tested during experimental vaccine-enhanced RSV infection [81] . AvCystatin prevented Th2-mediated immunopathology by ablating eosinophil influx and preventing weight loss and neutrophil recruitment. Furthermore, AvCystatin protects from excessive inflammation during the primary immune response by reducing neutrophil recruitment. AvCystatin acting on macrophages induces an influx of IL-10
Tregs into the lungs [95] .
The Allergic Response versus Helminth Infections
The arms race between helminths and immunity is well described [96] . The immune system functions to protect humans, with inflammation -a protective host response against infections and sterile injury -used to repair and resolve cellular and tissue injury. In the steady state, the immune system creates a state of homeostasis that maintains a healthy life span. In the event of immune dysregulation, aberrant inflammation can initiate chronic pathologies, leading to a spectrum of inflammatory and autoimmune diseases. Indeed, inflammation is central to many common diseases, such as arthritis, inflammatory bowel disease (IBD), obesity, and cancer. In such human disorders a widely used approach is to address the causes -spanning genetics to environmental factors -of the extreme aberrant immune responses when overt inflammatory disease develops.
From an evolutionary perspective, arthritis, IBD, obesity, and especially cancer, whilst not 'benefiting' from a long-living host, certainly put some pressure on the development of mechanisms to cope with or prevent the development of these conditions. In contrast, in helminth infections, a dead host usually means that the parasites' life cycle comes to an end as well. Coevolution of parasite and host has led to a fine balance between immune suppression and immunity. As described, the pulmonary damage is generally limited and not life-threatening itself because the immune response is already primed for tissue protection and modulated by the parasite. In the end, compromising a proinflammatory response against the helminth decreases host fitness costs, and an equilibrium between the immune response and damage (both from the immune response and the parasite) is reached. Medzhitov and colleagues [83] developed this thesis and, while it is known that disease tolerance where an infection may present limited immunopathology may develop in humans, the underlying mechanisms are not fully elucidated. One explanation -the IgE blocking hypothesis -is based on the observation that, during helminth infections, more polyclonal IgE is produced and thereby the high-affinity receptors for IgE (FceRI) on mast cells and basophils are saturated with low-affinity antibodies [97] . Therefore, basophils and mast cells, which otherwise would degranulate and release proallergic mediators -such as histamine, IL-4, IL-13, or prostaglandins -are not activated and thereby immediate allergic reactions are prevented. This hypothesis is still discussed as it has been found that suppression of basophil hyper-reactivity is dependent on host-derived IL-10, which also downregulates IgE production and thereby decreases the number of FcERI molecules on basophils [98] [99] [100] . Comparing histamine release from basophils before and after anthelmintic treatment showed basophil suppression during helminth infection [101] , proposing that helminths suppress allergy through the inhibition of basophil responses. However, one antigen was identified in N. brasiliensis-infected mice (Nb-Ag1), which induced Nb-Ag1-specific IgE and was able to bind to the pharyngeal region of the helminth [102] . Furthermore, specific IgE is present in the serum of infected mice, and Nb-Ag1-IgE can sensitize mast cells, and possibly basophils, to degranulate. Importantly, basophils sensitized by IgE raised during the first infection contribute to protection against a subsequent infection with the same helminth, arguing against the IgE-blocking hypothesis [102, 103] . Because IgE is only generated late during the immune response against the first infection with helminths, and IgE requires sequential switching from IgG1 + memory B cells, the IgE-blocking hypothesis should be investigated discriminating between first infections and subsequent challenge infections [104] .
Another model to reconcile the differences between allergies and helminth infections is the modified Th2 response evoked by helminth parasites. While allergens induce a potent proallergic type 2 cytokine-driven immune response, the helminth-induced immune response is modified by a regulating quality [62] . In this modified Th2 response, downstream effects are muted and result, for example, in the increase of noncomplement fixing IgG4 and IL-10, instead of inflammation-promoting IgG1, IgE, and IL-5 [105] . Evidence for this hypothesis comes from studies in which children who are exposed to cat allergens have reduced asthma levels. The decrease in Th2 responses is cat allergen-specific, as house dust mites do not confer a similar protection. The study found that high-level exposure to cat allergens induces IgG4 antibodies, which counteract allergen-specific IgE responses, and leads to increased IL-10 in exposed individuals and in in vitro cat-allergen-stimulated T cells [106] . Similarly, beekeepers who are constantly exposed to the major bee venom allergen phospholipase A2 show elevated IgG4-isotype-switched antibodies, which are produced by IL-10-producing Bregs [107] . Consequently, allergen-specific immunotherapy aiming to desensitize allergic patients by inducing allergen-specific Tregs show preferential switching of allergen-specific B cells from IgE towards the blocking IgG4 isotype [108] . Interestingly, in schistosome-infected mice, IL-10-producing Bregs that suppress allergic lung inflammation via Tregs are also elicited [24].
Schistosoma-infected asthma patients show an increase in pulmonary IL-10 [109] . Experimental data from Schistosoma-infected mice suggests that a compartmentalized modification by the schistosomes occurs specifically in the lung. These mice are refractory to ovalbumin (OVA)-induced airway inflammation, while systemic OVA-induced responses remain intact [110] . A possible explanation for this phenomenon lies within the parasite's life cycle. Exposed infected individuals constantly encounter Schistosoma cercariae. Because the worm cannot afford its host to die of hyper-parasitemia, it has evolved a mechanism preventing this: concomitant immunity. Brought forward almost 50 years ago [111] , concomitant immunity is a state in which the adult worms vaccinate their host with larval antigens, rendering the host immune to reinfections, thereby trapping newly invading larvae within the lung, while allowing the adult worm to survive. In order to control the pulmonary inflammation occurring in response to dead larvae in the lung, the aforementioned regulatory mechanisms prevent overwhelming immune responses with beneficial (allergies) and detrimental (viral and bacterial infections) side effects.
Concluding Remarks
Helminths have coevolved excellent strategies to deal with host immune responses, to limit direct and bystander tissue damage, while educating our immune system to tolerate infection. When helminth infections were common, the fitness advantage on our side was to tolerate the parasites. With increased sanitation, inhaled innocuous allergens trigger a similar response without the regulatory mechanisms triggered or provided by the presence of helminths. In particular, immune responses are heavily influenced by helminths passing through the lung or through their release of immunomodulators. Importantly, these potent immunomodulators are able to influence pulmonary immune responses with adult helminths dwelling at distal sites. Treatment with live helminths, although theoretically the most potent approach in terms of inducing a regulatory response, is not feasible because of the uncontrollable risk of the unknown unknowns -succumbing to infection, reactivating viruses, adverse side effects, and promoting unrelated malignancies (see Outstanding Questions). Identification of the active ingredient in the complex mixtures of excreted and secreted substances would allow us to exploit this knowledge for novel therapeutic approaches. While it remains to be determined if helminths could be a source of new therapies for lung inflammatory diseases, it is clear that fundamental research on the immunobiology of helminth modulation of lung immunity will continue to deliver new insight into the processes that regulate pulmonary function in health and disease. 
